HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease
Mattias Häger, Minka Živkovic, Prafull S. Gandhi, C.E. Rasmussen et autres
3 citationsBlood Advances
Catherine Rea
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
39Publications signalées
933Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Hemophilia Treatment and ResearchPlatelet Disorders and TreatmentsBlood properties and coagulationBlood Coagulation and Thrombosis MechanismsMyeloproliferative Neoplasms: Diagnosis and Treatment
Publications récentes
Velora pioneer, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of HMB-002 for prophylaxis in von Willebrand disease: A trial in progress
Priyanka Raheja, Amy Knott, Gillian Lowe, Olga Tsiamita et autres
2 citationsBlood
A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Matej Goricar et autres
0 citationsBlood
A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders
Prafull S. Gandhi, Minka Živkovic, Amalie Carnbring Bonde, Torben Elm et autres
20 citationsNature Cardiovascular Research
Athn Transcends Natural History Cohort Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia
Tammuella Chrisentery-Singleton, Carrie O’Neill, Catherine Rea, Jigar Amin et autres
0 citationsBlood
A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results
Catherine Rea, Thomas York, Ulrike Lorch, Kate Khair et autres
1 citationBlood
A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Thomas York et autres
2 citationsBlood
PB0228 A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: A First Report
Ulrike Lorch, Thomas York, Kate Khair, Luke Pembroke et autres
0 citationsResearch and Practice in Thrombosis and Haemostasis
OC 07.4 HMB-001, a Bispecific anti-FVIIa/anti-TLT-1 Antibody, Demonstrates Effect in Models of FVII Deficiency
P. Ferraresi, Marcello Baroni, Elena Tonetto, Amalie Carnbring Bonde et autres
0 citationsResearch and Practice in Thrombosis and Haemostasis
A first-in-human study of HMB-001 in patients with Glanzmann thrombasthenia
0 citationshttp://isrctn.com/
Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients
Sophia Stanford, Ashok Roy, Catherine Rea, Ben Harris et autres
0 citationsmedRxiv
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King’s College Hospital
Rachel E. Clapham, Victoria Speed, Julia Czuprynska, Anna Gazes et autres
12 citationsBritish Journal of Haematology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.